LPL Financial’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $833K | Buy |
484,327
+107,931
| +29% | +$186K | ﹤0.01% | 3876 |
|
|
2025
Q1 | $1.25M | Buy |
376,396
+125,689
| +50% | +$419K | ﹤0.01% | 3331 |
|
|
2024
Q4 | $1.86M | Buy |
250,707
+16,252
| +7% | +$120K | ﹤0.01% | 2912 |
|
|
2024
Q3 | $2.2M | Sell |
234,455
-9,384
| -4% | -$88.1K | ﹤0.01% | 2607 |
|
|
2024
Q2 | $1.96M | Buy |
243,839
+3,162
| +1% | +$25.4K | ﹤0.01% | 2602 |
|
|
2024
Q1 | $3.57M | Buy |
240,677
+111,541
| +86% | +$1.65M | ﹤0.01% | 2036 |
|
|
2023
Q4 | $1.05M | Buy |
129,136
+25,592
| +25% | +$208K | ﹤0.01% | 2980 |
|
|
2023
Q3 | $471K | Buy |
103,544
+29,108
| +39% | +$132K | ﹤0.01% | 3511 |
|
|
2023
Q2 | $524K | Buy |
74,436
+5,667
| +8% | +$39.9K | ﹤0.01% | 3377 |
|
|
2023
Q1 | $420K | Buy |
68,769
+7,950
| +13% | +$48.6K | ﹤0.01% | 3460 |
|
|
2022
Q4 | $389K | Buy |
60,819
+13,999
| +30% | +$89.5K | ﹤0.01% | 3450 |
|
|
2022
Q3 | $449K | Sell |
46,820
-1,194
| -2% | -$11.5K | ﹤0.01% | 3231 |
|
|
2022
Q2 | $530K | Buy |
48,014
+23,018
| +92% | +$254K | ﹤0.01% | 3131 |
|
|
2022
Q1 | $416K | Buy |
24,996
+5,929
| +31% | +$98.7K | ﹤0.01% | 3323 |
|
|
2021
Q4 | $364K | Buy |
19,067
+958
| +5% | +$18.3K | ﹤0.01% | 3537 |
|
|
2021
Q3 | $447K | Buy |
18,109
+1,865
| +11% | +$46K | ﹤0.01% | 3304 |
|
|
2021
Q2 | $423K | Buy |
+16,244
| New | +$423K | ﹤0.01% | 3284 |
|
|
2021
Q1 | – | Sell |
-5,465
| Closed | -$254K | – | 4091 |
|
|
2020
Q4 | $254K | Sell |
5,465
-1,404
| -20% | -$65.3K | ﹤0.01% | 3329 |
|
|
2020
Q3 | $226K | Buy |
+6,869
| New | +$226K | ﹤0.01% | 3095 |
|
|
2019
Q4 | – | Sell |
-25,097
| Closed | -$457K | – | 3352 |
|
|
2019
Q3 | $457K | Buy |
+25,097
| New | +$457K | ﹤0.01% | 2322 |
|